Malaria Diagnostics Market to Grow at a Promising CAGR 5.1% by 2026, Exclusive Report

According to the report, the global malaria diagnostics industry was estimated at $728,870 thousand in 2018, and is expected to hit $1,085,106 thousand by 2026, registering a CAGR of 5.1% from 2019 to 2026.

The study analyzes the important strategies, drivers, competition, market dynamics, size, and important investment regions.

Key Takeaways:

The malaria diagnostics market refers to the global market for products and technologies used in diagnosing malaria infections.

The market is driven by the high prevalence of malaria in many parts of the world, particularly in regions such as Sub-Saharan Africa, Southeast Asia, and Latin America.

Rapid diagnostic tests (RDTs) are the most commonly used diagnostic method for malaria. They provide quick results and are relatively inexpensive.

Molecular diagnostics, such as polymerase chain reaction (PCR), are increasingly being adopted for malaria diagnosis due to their high sensitivity and ability to detect low-level infections.

The market is witnessing advancements in technology, including the development of automated diagnostic platforms and point-of-care devices, which improve testing accuracy and convenience.

Governments and international organizations are actively involved in initiatives to control and eliminate malaria, leading to increased demand for malaria diagnostic tools.

Request Sample Copy of the Report:

https://www.alliedmarketresearch.com/request-sample/285

Market Drivers:

High Prevalence of Malaria: Malaria remains a significant global health concern, especially in regions with high transmission rates, such as Sub-Saharan Africa, Southeast Asia, and Latin America. The high prevalence of malaria creates a demand for effective and accurate diagnostic tools.

Government and International Initiatives: Governments, non-profit organizations, and international bodies are actively involved in malaria control and elimination programs. These initiatives drive the demand for malaria diagnostics as part of comprehensive malaria control strategies.

Technological Advancements: The market is experiencing advancements in diagnostic technologies, including the development of rapid diagnostic tests (RDTs) and molecular diagnostics. These innovations offer improved sensitivity, specificity, and ease of use, enhancing the accuracy and efficiency of malaria diagnosis.

Increasing Access to Healthcare: Efforts to improve access to healthcare services in remote and resource-limited areas have led to a greater demand for point-of-care malaria diagnostic devices. Portable and user-friendly diagnostic tools enable early and accurate diagnosis in underserved regions.

Market Segmentation:

Diagnostic Method: a. Rapid Diagnostic Tests (RDTs): These are simple, low-cost, and easy-to-use tests that detect malaria antigens in a patient’s blood. b. Molecular Diagnostics: This includes techniques such as Polymerase Chain Reaction (PCR) that detect the presence of malaria parasites’ DNA or RNA in the blood.

End User: a. Hospitals and Clinics: Diagnostic tests are performed in healthcare facilities, including hospitals and clinics, by trained healthcare professionals. b. Diagnostic Laboratories: Specialized laboratories conduct malaria diagnostic tests, particularly molecular diagnostics. c. Research Institutes: Research institutions play a role in developing and evaluating new diagnostic methods and technologies.

Distribution Channel: a. Hospitals and Clinics: Diagnostic tests are conducted and results are provided within the healthcare facility itself. b. Retail Pharmacies and Drug Stores: Point-of-care diagnostic tests, primarily RDTs, may be available for purchase over the counter. c. Online Platforms: Some diagnostic kits and devices may be purchased through online platforms and delivered to the consumer’s location.

Request for Customization –

https://www.alliedmarketresearch.com/request-for-customization/285

Regional Growth Dynamics:

Based on geography, LAMEA contributed to 94% of the global malaria diagnostics market revenue in 2018, and is anticipated to maintain the lion’s share till 2026. At the same time, the Asia-Pacific region would showcase the fastest CAGR of 6.1% during the study period. Surge in awareness regarding the use of antimalarial drugs in this region has propelled the growth. However, North America would register a CAGR of 4.1% by 2026.

Competitive Landscape:

• Abbott Laboratories
• BioMérieux SA
• bioMérieux SA
• Cepheid Inc. (a Danaher Corporation company)
• Chembio Diagnostic Systems, Inc.
• Meridian Bioscience, Inc.
• Premier Medical Corporation Ltd.
• QIAGEN N.V.
• Roche Diagnostics (a division of F. Hoffmann-La Roche Ltd)
• Sysmex Corporation

Recent developments:

• Point-of-Care Molecular Diagnostics: There have been advancements in developing portable and user-friendly molecular diagnostic devices for malaria. These point-of-care molecular diagnostics enable rapid and accurate detection of malaria parasites, including drug-resistant strains, at the point of patient care.
• Digital and AI-based Solutions: The integration of digital technologies and artificial intelligence (AI) in malaria diagnostics is gaining momentum. These solutions aim to improve accuracy, speed, and efficiency in diagnosing malaria infections by analyzing digital images of blood samples or utilizing AI algorithms for interpretation.
• Multiplex Assays: Multiplex assays enable the simultaneous detection of multiple malaria species or the differentiation between malaria and other febrile illnesses. These assays save time, reduce costs, and provide comprehensive diagnostic information, aiding in appropriate treatment decisions.

Buy this Premium Research Report:

https://www.alliedmarketresearch.com/purchase-enquiry/285

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives

Browse more latest healthcare reports:

Mobile Imaging Market by Service Type (X-Ray, CT Scan, Ultrasound, MRI, Mammography, Nuclear Imaging, and Others), Patient Type (Adult and Pediatric), and Facility (Hospitals & Clinics, Home Healthcare, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030

Rapid Acting Insulin Market by Product Type (Insulin Lispro, Insulin Aspart, and Insulin Glulisine), Indication (Type 1 Diabetes and Type 2 Diabetes), and Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Providers): Global Opportunity Analysis and Industry Forecast, 2020-2027

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com